Published in N Engl J Med on January 30, 1992
Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J (1993) 3.54
Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J (2004) 2.71
Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. J Clin Invest (2008) 2.43
Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation (2009) 2.09
Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol (2013) 1.93
Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med (2001) 1.75
Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol (1996) 1.66
GPVI and alpha2beta1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow. Blood (2005) 1.47
Inhibition of thrombosis and intimal thickening by in situ photopolymerization of thin hydrogel barriers. Proc Natl Acad Sci U S A (1994) 1.46
Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest (2001) 1.41
Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest (1998) 1.40
Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc (2009) 1.38
von Willebrand factor. J Clin Invest (1997) 1.37
Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol (1997) 1.37
The vascular endothelium. A new horizon. Ann Surg (1993) 1.32
Influence of intracoronary attenuation on coronary plaque measurements using multislice computed tomography: observations in an ex vivo model of coronary computed tomography angiography. Eur Radiol (2005) 1.31
PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation. J Biol Chem (2006) 1.27
ROCKs as therapeutic targets in cardiovascular diseases. Expert Rev Cardiovasc Ther (2005) 1.25
Old concepts and new developments in the study of platelet aggregation. J Clin Invest (2000) 1.22
d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc Natl Acad Sci U S A (1995) 1.07
The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis. J Clin Invest (1999) 1.05
Absolute coronary artery calcium scores are superior to MESA percentile rank in predicting obstructive coronary artery disease. Int J Cardiovasc Imaging (2008) 1.04
In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model. Arterioscler Thromb Vasc Biol (2001) 1.03
Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound. Heart (1999) 1.01
Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart (2004) 0.96
In vivo optical coherence tomography of experimental thrombosis in a rabbit carotid model. Heart (2007) 0.95
Platelet membrane glycoprotein Ibalpha gene -5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis. Heart (2002) 0.93
Mean platelet volume reproducibility and association with platelet activity and anti-platelet therapy. Platelets (2013) 0.92
Impact of smoking on the outcome of patients treated with drug-eluting stents: 1-year results from the prospective multicentre German Drug-Eluting Stent Registry (DES.DE). Clin Res Cardiol (2010) 0.92
MR plaque imaging of the carotid artery. Neuroradiology (2010) 0.91
Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease. PLoS One (2012) 0.91
Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1α and vascular endothelial growth factor signaling. Circulation (2014) 0.91
Coronary plaque quantification by voxel analysis: dual-source MDCT angiography versus intravascular sonography. AJR Am J Roentgenol (2009) 0.90
Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients. Cardiovasc Diabetol (2009) 0.90
Atherosclerosis: what is it and why does it occur? Br Heart J (1993) 0.90
Multicontrast-weighted magnetic resonance imaging of atherosclerotic plaques at 3.0 and 1.5 Tesla: ex-vivo comparison with histopathologic correlation. Eur Radiol (2006) 0.90
Periodontitis as a risk factor for cardiovascular disease: the role of anti-phosphorylcholine and anti-cardiolipin antibodies. Hippokratia (2008) 0.89
Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2. Cardiovasc Diabetol (2009) 0.89
Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging (2008) 0.89
Role of fibrin D-dimer testing in emergency medicine. Emerg Med J (2003) 0.89
Platelet deposition in non-parallel flow: influence of shear stress and changes in surface reactivity. J Math Biol (2008) 0.89
Comparison of iodinated contrast media for the assessment of atherosclerotic plaque attenuation values by CT coronary angiography: observations in an ex vivo model. Br J Radiol (2013) 0.88
Influence of convolution filtering on coronary plaque attenuation values: observations in an ex vivo model of multislice computed tomography coronary angiography. Eur Radiol (2007) 0.87
Bioequivalence and tolerability study of two brands of clopidogrel tablets, using inhibition of platelet aggregation and pharmacodynamic measures. Curr Ther Res Clin Exp (2003) 0.87
30-day in-hospital mortality after acute myocardial infarction in Tuscany (Italy): an observational study using hospital discharge data. BMC Med Res Methodol (2012) 0.86
Relationship between retinal vascular caliber and coronary artery disease in patients with non-alcoholic fatty liver disease (NAFLD). Int J Environ Res Public Health (2013) 0.85
Antiplatelet drugs in cardiological practice: established strategies and new developments. Vasc Health Risk Manag (2008) 0.84
Mineral volume and morphology in carotid plaque specimens using high-resolution MRI and CT. Arterioscler Thromb Vasc Biol (2005) 0.84
Acute coronary syndromes: pathology, diagnosis, genetics, prevention, and treatment. Circ Res (2014) 0.84
Exposure to smoking cues: cardiovascular and autonomic effects. Addict Behav (2011) 0.84
Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease. Heart (1996) 0.83
Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment. Clin Res Cardiol (2007) 0.83
Evidence for a protein S receptor(s) on human vascular smooth muscle cells. Analysis of the binding characteristics and mitogenic properties of protein S on human vascular smooth muscle cells. Biochem J (1995) 0.83
Integrative Multi-omic Analysis of Human Platelet eQTLs Reveals Alternative Start Site in Mitofusin 2. Am J Hum Genet (2016) 0.83
Atherosclerosis of the descending aorta predicts cardiovascular events: a transesophageal echocardiography study. Cardiovasc Ultrasound (2004) 0.83
Intravascular ultrasound assessment of the association between spatial orientation of ruptured coronary plaques and remodeling morphology of culprit plaques in ST-elevation acute myocardial infarction. Heart Vessels (2011) 0.82
PGE2 decreases reactivity of human platelets by activating EP2 and EP4. Thromb Res (2010) 0.82
The impact of carotid plaque presence and morphology on mortality outcome in cardiological patients. Cardiovasc Ultrasound (2006) 0.82
Visualising noncalcified coronary plaques by CT. Int J Cardiovasc Imaging (2005) 0.81
Low bone mineral density is not associated with angiographically determined coronary atherosclerosis in men. Osteoporos Int (2009) 0.81
Antiplatelet treatment for coronary heart disease. Heart (2007) 0.80
Intracranial atherosclerotic disease; current options for surgical or medical treatment. J Korean Neurosurg Soc (2007) 0.80
Evidence for the role of Epstein Barr Virus infections in the pathogenesis of acute coronary events. PLoS One (2013) 0.80
Hostility and platelet reactivity in individuals without a history of cardiovascular disease events. Psychosom Med (2009) 0.80
Coronary artery ectasia in Egyptian patients with coronary artery disease. Tex Heart Inst J (1997) 0.79
Adenosine and blood platelets. Purinergic Signal (2011) 0.79
Oral health status of patients with acute coronary syndrome--a case control study. BMC Oral Health (2012) 0.79
Coronary atherosclerosis is already ongoing in pre-diabetic status: Insight from intravascular imaging modalities. World J Diabetes (2015) 0.79
Circulating platelet and neutrophil activation correlates with the clinical course of unstable angina. Heart Vessels (2007) 0.78
A pathological study of the epidemiology of atherosclerosis in Mexico city. Cardiol Res Pract (2014) 0.78
Vascular targeting of antithrombotic agents. IUBMB Life (2011) 0.78
Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo. Br J Pharmacol (1995) 0.78
A few immobilized thrombins are sufficient for platelet spreading. Biophys J (2011) 0.78
Myocardial infarction in major noncardiac surgery: Epidemiology, pathophysiology and prevention. Heart Int (2006) 0.77
Glycine reduces platelet aggregation. Amino Acids (2012) 0.77
Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction. Br J Pharmacol (2002) 0.77
The crystal structure of the active domain of Anopheles anti-platelet protein, a powerful anti-coagulant, in complex with an antibody. J Biol Chem (2014) 0.77
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease. Curr Control Trials Cardiovasc Med (2001) 0.76
Genetic testing for early detection of individuals at risk of coronary heart disease and monitoring response to therapy: challenges and promises. Curr Atheroscler Rep (2011) 0.76
A comparison of tissue prolapse with optical coherence tomography and intravascular ultrasound after drug-eluting stent implantation. Int J Cardiovasc Imaging (2014) 0.76
Testosterone Replacement Therapy Prevents Alterations of Coronary Vascular Reactivity Caused by Hormone Deficiency Induced by Castration. PLoS One (2015) 0.75
Pregnancy Associated Plasma Protein-A (PAPP-A) Levels in Acute Coronary Syndrome: A Case Control Study in a Tertiary Care Centre. Indian J Clin Biochem (2014) 0.75
Brachial artery vasoreactivity is associated with cross-sectional and longitudinal anatomical measures of atherosclerosis in postmenopausal women with coronary artery disease. Atherosclerosis (2007) 0.75
Current perspectives on laboratory markers for the assessment of cardiovascular disease and myocardial damage. Indian J Clin Biochem (1999) 0.75
Cardiovascular molecular imaging as a tool to study biology. Theranostics (2013) 0.75
The role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (statins) in modern rheumatology. Ther Adv Musculoskelet Dis (2010) 0.75
Non-invasive detection of vulnerable coronary plaque. World J Cardiol (2011) 0.75
Distribution of ultrasonic radiofrequency signal amplitude detects lipids in atherosclerotic plaque of coronary arteries: an ex-vivo study. Cardiovasc Ultrasound (2008) 0.75
Early experience with a helical coronary thrombectomy device in patients with acute coronary thrombosis. Heart (2002) 0.75
Association of smoking with restenosis and major adverse cardiac events after coronary stenting: A meta-analysis. Pak J Med Sci (2015) 0.75
Historical perspective on ADP-induced platelet activation. Purinergic Signal (2011) 0.75
Raised interleukin 6 concentrations as a predictor of postangioplasty restenosis. Heart (2000) 0.75
Clinical outcome of urgent coronary artery bypass grafting. J Korean Med Sci (2007) 0.75
Optimizing the imaging protocol for ex vivo coronary artery wall using high-resolution MRI: an experimental study on porcine and human. Korean J Radiol (2013) 0.75
Mauritia flexuosa Presents In Vitro and In Vivo Antiplatelet and Antithrombotic Activities. Evid Based Complement Alternat Med (2013) 0.75
Predictors of Peak Troponin Level in Acute Coronary Syndromes: Prior Aspirin Use and SYNTAX Score. Int J Angiol (2015) 0.75
High levels of LDL-C combined with low levels of HDL-C further increase platelet activation in hypercholesterolemic patients. Braz J Med Biol Res (2014) 0.75
The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med (1992) 6.41
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation (1987) 5.73
The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med (1992) 3.53
Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis. J Am Coll Cardiol (1997) 3.06
Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A (1999) 2.98
Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest (1990) 2.55
Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation (2001) 2.41
Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol (1990) 2.30
Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation (2000) 2.29
Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation (1995) 2.29
Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation (1990) 2.01
Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation (1999) 1.94
Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation (1998) 1.94
Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest (1996) 1.92
Cardiovascular disease in women. Circulation (1993) 1.87
Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med (1984) 1.85
A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med (1982) 1.82
Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol (2000) 1.81
Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood (2000) 1.59
D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain. Am Heart J (2000) 1.57
Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation (1990) 1.57
Insights into the pathogenesis of acute ischemic syndromes. Circulation (1988) 1.50
Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy. Circulation (1981) 1.49
Refractory prinzmetal angina treated with cyproheptadine. Ann Intern Med (1994) 1.48
Atrial fibrillation--risk marker for stroke. N Engl J Med (1990) 1.46
Acute coronary syndromes: biology. Lancet (1999) 1.46
Flavone-8-acetic acid (Flavonoid) profoundly reduces platelet-dependent thrombosis and vasoconstriction after deep arterial injury In vivo. Circulation (2000) 1.45
Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol (1983) 1.45
Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res (1985) 1.42
Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation (1997) 1.39
Coronary excimer laser angioplasty: reduced complications and indium-111 platelet accumulation compared with thermal laser angioplasty. J Am Coll Cardiol (1990) 1.39
The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis (2000) 1.38
The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler Thromb Vasc Biol (1999) 1.37
Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol (1994) 1.37
Testing platelet activation with a shear-dependent platelet function test versus aggregation-based tests: relevance for monitoring long-term glycoprotein IIb/IIIa inhibition. Circulation (2001) 1.35
In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation (2000) 1.35
A dilemma for the 1990s. Choosing appropriate experimental animal model for the prevention of restenosis. Circulation (1992) 1.34
Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile. J Am Coll Cardiol (1999) 1.33
High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. Lab Invest (1989) 1.26
Echocardiographic "smoke" is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces. J Am Coll Cardiol (1992) 1.24
Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med (2001) 1.24
Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med (1997) 1.23
Complete occlusion of the left main coronary artery and the importance of coronary collateral circulation. Mayo Clin Proc (1977) 1.22
Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. Circulation (1986) 1.21
Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation (1989) 1.19
Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. J Am Coll Cardiol (1995) 1.18
Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay. J Thromb Haemost (2009) 1.16
Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model. Arteriosclerosis (1986) 1.15
Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets. Circulation (1994) 1.12
International conference on the healthy effect of virgin olive oil. Eur J Clin Invest (2005) 1.12
Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation (1989) 1.11
Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation (2001) 1.10
LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2000) 1.10
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib. Ann Rheum Dis (2007) 1.09
Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. N Engl J Med (1984) 1.08
Coronary atherosclerosis. A multifactorial disease. Circulation (1993) 1.08
Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. Atherosclerosis (2000) 1.08
Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. J Am Coll Cardiol (1985) 1.07
Effects of dietary supplementation with cod-liver oil on endothelium-dependent responses in porcine coronary arteries. Circulation (1987) 1.07
Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. Circulation (1986) 1.05
HDL-induced prostacyclin release in smooth muscle cells is dependent on cyclooxygenase-2 (Cox-2). Arterioscler Thromb Vasc Biol (1997) 1.05
Effect of p27 deficiency and rapamycin on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model. Lab Invest (2001) 1.05
Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. J Am Coll Cardiol (1985) 1.05
Plaque rupture, thrombosis, and therapeutic implications. Haemostasis (1996) 1.04
High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol (1995) 1.03
Noninvasive radioisotopic technique for detection of platelet deposition in coronary artery bypass grafts in dogs and its reduction with platelet inhibitors. Circulation (1979) 1.02
Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis. Circulation (2000) 1.02
Platelet glycoprotein IIb/IIIa receptor blockade in unstable coronary disease. N Engl J Med (1998) 1.01
New understanding of atherosclerosis (clinically and experimentally) with evolving MRI technology in vivo. Ann N Y Acad Sci (2001) 0.99
High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model. Atherosclerosis (2000) 0.99
Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease. JAMA (1999) 0.99
Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit. Arteriosclerosis (1989) 0.99
Platelets, vasoconstriction, and nitroglycerin during arterial wall injury. A new antithrombotic role for an old drug. Circulation (1988) 0.98